About
OpenEye Scientific is a leading provider of computational molecular design software used to accelerate drug discovery and lead optimization. Now integrated into Cadence Solutions, OpenEye offers the Orion® Molecular Design Platform—a cloud-native environment supporting the full small molecule and antibody discovery pipeline. Its tools combine physics-based methods with AI to enable ligand- and structure-based virtual screening, free energy perturbation (FEP) calculations, molecular dynamics simulations, quantum chemistry, and pocket detection. Key products include ROCS X for AI-enabled 3D molecular search across trillions of compounds, Target X for target exploration, and a dedicated Antibody Discovery Suite supporting NGS-based library design and engineering. The platform provides access to over 24 billion 3D conformer-expanded compounds from commercial vendors, 2.2 million searchable protein binding sites, and over 100,000 docking- and MD-ready protein structures. OpenEye also offers cheminformatics and modeling toolkits, visualization and data management tools, and curated molecular databases, along with professional services including drug discovery consulting and custom scientific method development. Academic licensing is available for research institutions. The platform is designed for computational chemists, medicinal chemists, and structural biologists working across biotech, pharma, agrochemicals, and flavors & fragrances sectors.
Key Features
- Orion® Cloud Molecular Design Platform: A scalable cloud-native environment integrating virtual screening, MD simulations, FEP calculations, and data management for the full drug discovery pipeline.
- ROCS X – AI-Enabled Molecular Search: Search billions of ligands in seconds (2D) or minutes (3D) and dock billions of compounds in hours using AI-accelerated shape and electrostatics matching.
- Free Energy Perturbation (FEP): Physics-based free energy predictions for accurate affinity ranking and lead optimization, enabling data-driven compound prioritization.
- Antibody Discovery Suite: End-to-end tools for antibody engineering and library design using next-generation sequencing (NGS), supporting structure-based and AI-guided optimization.
- Curated Ultra-Large Compound Databases: Access over 24 billion 3D conformer-expanded purchasable compounds, 2.2M protein binding sites, and 100K+ docking-ready protein structures.
Use Cases
- Virtual screening of billion-scale compound libraries to identify novel drug candidates in early-stage discovery programs.
- Lead optimization using free energy perturbation to rank compound series and guide medicinal chemistry decisions.
- Antibody discovery and engineering using NGS-based library design and structure-guided computational methods.
- Crystal structure prediction and drug formulation consulting to support pharmaceutical development pipelines.
- Academic and industrial cheminformatics research leveraging curated molecular databases and modeling toolkits.
Pros
- Massive Scale Virtual Screening: Enables screening of billions to trillions of compounds via highly optimized 2D/3D search algorithms, drastically compressing hit discovery timelines.
- Comprehensive Drug Discovery Toolkit: Covers the entire pipeline from target exploration and hit identification through lead optimization, formulation, and antibody engineering in a single platform.
- Cloud-Native Scalability: Orion® and Cadence OnCloud allow teams to run compute-intensive simulations and large-scale docking without on-premise hardware investment.
- Rigorous Physics-Based Methods: Uses proven quantum chemistry, FEP, and molecular dynamics approaches alongside AI, ensuring high scientific accuracy for critical design decisions.
Cons
- Enterprise-Level Pricing: Commercial licensing is designed for pharmaceutical and biotech organizations; costs may be prohibitive for smaller startups or independent researchers.
- Steep Learning Curve: Effective use requires expertise in computational chemistry and cheminformatics, making onboarding challenging for non-specialists.
- Niche Industry Focus: The platform is purpose-built for drug discovery and closely related fields, limiting its applicability outside pharmaceutical, biotech, and agrochemical sectors.
Frequently Asked Questions
What is OpenEye Scientific?
OpenEye Scientific, now part of Cadence Solutions, is a provider of molecular modeling and cheminformatics software used to accelerate drug discovery, lead optimization, and pharmaceutical formulation through physics-based and AI-driven computation.
What is the Orion® platform?
Orion® is OpenEye's cloud-native molecular design platform that integrates virtual screening, molecular dynamics, free energy perturbation, and data management tools into a unified environment accessible via the web.
How many compounds are available for virtual screening?
OpenEye provides access to over 24 billion 3D conformer-expanded compounds from commercial vendors, enabling ultra-large-scale virtual screening campaigns.
Is academic licensing available?
Yes, OpenEye Scientific offers academic licensing options for research institutions and universities, making its software accessible for non-commercial scientific research.
What types of simulations does OpenEye support?
OpenEye supports molecular dynamics (MD) simulations, free energy perturbation (FEP), quantum chemistry calculations, ligand- and structure-based virtual screening, and AI-enhanced molecular shape searching.
